Back to Blog

Repeated IVF Failure and the Immune System: What Is Actually Known?

Dr. Senai Aksoy · · 6 min read
Medically reviewed on 18 July 2026 - Dr. Senai Aksoy
ivffailureimmuneautoimmune
Repeated IVF Failure and the Immune System: What Is Actually Known?

Key Takeaways

Immune factors may play a role in a small subset of patients with repeated IVF failure, but they should not be treated as the default explanation after one unsuccessful cycle. Current evidence supports ruling out more common embryo, uterine, tubal, and sperm factors first, because many immune tests and immune treatments remain uncertain outside selected cases.

Key evidence: ESHRE — Recurrent implantation failure guideline ASRM — Role of immunotherapy in IVF guideline

On this page

Repeated IVF Failure and the Immune System: What Is Actually Known?

Patients often hear that the immune system may explain repeated implantation failure or miscarriage after IVF. There’s some truth to that, but the idea gets oversimplified more often than not. Reproductive immunology is a real field — many of its proposed tests and treatments are still debated, though, and not every failed cycle should trigger an immune workup.

Why the Immune System Is Discussed

Short Answer:

Pregnancy depends on a controlled local immune response rather than immune silence, which is why researchers ask whether abnormal immune signaling could interfere with implantation — but that biological plausibility doesn’t mean it explains most failed cycles.

Pregnancy requires a balance between immune defense and tolerance. The embryo contains genetic material from both parents, so implantation depends on a controlled local immune response rather than simple immune silence. This has led researchers to ask whether abnormal immune signaling, inflammatory activation, or autoimmune disease could interfere with implantation in some patients.

That is biologically plausible. The harder question is how often it changes IVF decisions in practice.

Can IVF Trigger Autoimmune Disease?

Short Answer:

There’s no solid evidence that IVF stimulation or embryo transfer triggers a new autoimmune disease in a previously healthy woman. The picture only changes if an autoimmune disease is already present, and how it changes depends on which disease.

There’s no solid evidence that IVF stimulation or embryo transfer sets off a new autoimmune disease in a woman who was previously healthy. The cytokine rises seen during ovarian stimulation are expected and short-lived — they settle on their own and don’t amount to disease onset. There’s also no credible biological mechanism linking embryo transfer itself to systemic autoimmunity.

The picture changes if an autoimmune disease is already present, and it changes differently depending on which one. In multiple sclerosis, some studies report a higher relapse rate and more MRI activity after ART; Sparaco et al. (2023) recommend GnRH-antagonist protocols specifically to bring that risk down. In systemic lupus erythematosus, a large prospective French cohort found no increase in flares or pregnancy complications after fertility treatment — as long as the disease was clinically inactive going in (Dernoncourt et al., 2024).

If you have a known autoimmune, neurological, or rheumatological condition, it’s worth discussing the planned stimulation protocol with both your specialist — rheumatologist or neurologist — and your fertility team beforehand. Which protocol fits best — a GnRH-antagonist approach is one option — can depend on the specific disease.

Dr Aksoy’s clinical perspective

“Having an MS or lupus diagnosis doesn’t automatically mean you can’t have IVF. But there’s no such thing as a ‘standard protocol’ for you. We first look at how active the disease is, what medication you’re on, and whether pregnancy itself would be safe for you — then we plan stimulation around that.

“With an MS patient, I specifically emphasise: our goal isn’t just to retrieve eggs — it’s to do that without disturbing the balance of your disease. We review your last relapse and your medications together with your neurologist. When needed, we choose a shorter, more controlled antagonist protocol to reduce hormonal fluctuation and OHSS risk as much as possible.

“With lupus, the conversation is a little different: it matters that the disease is quiet. Active disease — especially with kidney involvement or antiphospholipid syndrome — needs a rheumatology assessment first. Rising oestrogen and pregnancy itself can matter for both disease activity and clotting risk. So we don’t start a protocol without knowing your medications, your antibody status, and your history of thrombosis.

“Where it’s needed, we may consider low-dose stimulation, an antagonist protocol, trigger methods that lower OHSS risk, and freezing all embryos to move the transfer to a safer window. But these aren’t a fixed recipe applied because of the diagnosis — they’re decisions made for that specific patient.

“Two opposite extremes bother me the most: telling a patient upfront that IVF is dangerous for her because of an autoimmune disease and ruling her out, or giving her the same protocol as everyone else as if the disease weren’t there at all. The right approach sits between the two — we’re not just stimulating your ovaries, we’re treating the whole patient. Keeping your disease under control and reaching pregnancy safely is as much a part of the treatment as the outcome itself.”

More Common Causes Still Come First

Short Answer:

Before considering an immune cause, clinicians usually rule out embryo quality, maternal age, sperm factors, and uterine cavity findings — explanations that are more common and more actionable than an immune theory alone.

Before attributing repeated failure to immune causes, clinicians usually review:

Taken together, these possibilities are usually both more common and more actionable than an immune theory on its own.

When an Immune Workup May Be Considered

Short Answer:

Immune evaluation becomes more reasonable after repeated implantation failure, recurrent pregnancy loss, known autoimmune disease, or antiphospholipid syndrome suspicion — not automatically after a single failed cycle.

Immune-related assessment may be considered more seriously when there is:

Even in these settings, testing should be selective. Broad panels marketed after one failed transfer often go beyond what evidence clearly supports.

The Problem With Many Immune Tests

Short Answer:

Peripheral immune markers such as natural killer cell counts or cytokine panels are hard to interpret reliably — an abnormal result doesn’t prove it caused implantation failure, and normal ranges vary across labs.

Tests involving natural killer cells, cytokine panels, and other peripheral immune markers come up often in these conversations, but they’re genuinely hard to interpret. An abnormal marker doesn’t prove it caused implantation failure, and normal ranges aren’t always standardized from lab to lab.

For that reason, professional guidance tends to be cautious. The immune hypothesis should be individualized rather than used as a universal explanation.

What About Immune Treatments?

Short Answer:

Immune-directed treatments such as steroids, IVIG, intralipids, or anticoagulation may help in selected, well-diagnosed cases, but routine use for broadly defined implantation failure remains controversial given mixed evidence and real cost or risk.

Steroids, intralipids, IVIG, anticoagulation, and other immune-directed treatments are sometimes proposed after repeated IVF failure. Some may be appropriate in selected diagnoses, especially when a clear autoimmune or clotting condition is present. But routine use for broadly defined implantation failure remains controversial because evidence is mixed and some treatments carry cost or risk.

The key point is that treatment should follow a defensible diagnosis rather than a vague hope that “something immune” is being covered.

Conclusion

The immune system may matter in a subset of repeated IVF failures, but it’s rarely the first explanation worth reaching for. A careful review of embryo, uterine, tubal, and male-factor issues should usually come first. When immune investigation is considered, it works best applied selectively, with a clear-eyed view of how much about these tests and therapies is still unsettled.

Request a Case Review

If you’ve had more than one unsuccessful cycle and are wondering whether immune factors are relevant to your case, a structured review of your embryo, uterine, and prior-cycle findings is a more useful starting point than an immune panel alone. You can request a confidential case review to have your file assessed before deciding on next steps.

FAQ

Should immune testing be done after one failed IVF cycle?

Usually no. One failed transfer is common and does not by itself prove an immune problem. Embryo, uterine, tubal, sperm, and transfer factors usually come first.

Are natural killer cell tests definitive?

No. Peripheral immune markers can be difficult to interpret, and an abnormal result does not automatically prove that immune activity caused implantation failure.

When is immune evaluation more reasonable?

It may be considered after repeated implantation failure, recurrent pregnancy loss, known autoimmune disease, antiphospholipid syndrome suspicion, or a pattern suggesting clotting or inflammatory disease.

Are immune treatments harmless?

No. Steroids, IVIG, intralipids, and anticoagulation can carry cost, side effects, or procedure burden. Treatment should follow a clear diagnosis whenever possible.

Sources

Add as a Preferred Source on Google

You can add draksoyivf.com as one of your preferred health information sources on Google.

Add on Google
Dr. Senai Aksoy

Dr. Senai Aksoy studied and trained in France before returning to Turkey, where he was a founding member of the ICSI team at Sevgi Hospital, Ankara — the country's first ICSI centre (1994-95) — and a co-author on the first Turkish ICSI publications produced in collaboration with the Brussels Van Steirteghem group (Human Reproduction, 1996; PMID 8671323). He helped build the IVF programme at the American Hospital Istanbul and has been running his own fertility practice since 1998.

Verified profiles: PubMed ORCID LinkedIn

Instagram YouTube

The content has been created by Dr. Senai Aksoy and medically approved.